Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: Pain, Postoperative, Acute Pain, Facial Pain

In brief

The purpose of this study is to assess the effectiveness of pre-operative administration of gabapentin 900 mg in management of acute post-operative pain in patients undergoing oral and maxillofacial surgical procedures.

Key facts

Study ID

NCT02957097

Run by

Massachusetts General Hospital

People needed

0

Starts

2019-09-01

Expected to finish

2021-07-01

Last updated by the study team

2023-01-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female participants, of any race, between ages of 18 - 65 years.
• Participants undergoing unilateral or bilateral Lefort osteotomy, unilateral or bilateral mandibular inverted-L or sagittal split osteotomy with or without genioplasty, temporomandibular joint arthroplasty with or without total joint replacement prosthesis.

You may not qualify if…

• Participants who are pregnant.
• Participants allergic to gabapentin.
• Participants with a history of alcohol, or drug abuse.
• Participants who are unwilling to participate, or are non-compliant to the guidelines of the investigation.

Where it is running

• Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.